Page 2 - Pharma Analyst News Today

29 Dec, 2023 Indias fight against rare diseases needs more focus on awareness and diagnosis, says GlobalData Share Print...

In India, it appears that a key obstacle to effectively combating rare diseases is lack of awareness and insufficient diagnosis.

A major obstacle to effectively combating rare diseases in India is the lack of awareness and inadequate diagnosis in the country, according to a report on Friday.In November 2023, the Union Health Ministry authorised the sale of four generic ...

27 Dec, 2023 Gaucher disease market to reach $1.3 billion across 7MM in 2032, forecasts GlobalData Share Print page ...

26 Dec, 2023 Dual orexin receptor antagonists to drive insomnia market across 7MM to $4.1 billion in 2032, says GlobalData Share ...

Mounjaro, a weight loss medication, is projected to outpace Ozempic, driven by convincing clinical results and anticipated sales of $27 billion by 2029.

Eli Lilly's Mounjaro is poised to surpass Novo Nordisk's Ozempic (semaglutide) and become the leading drug by sales in the obesity and diabetes market, according to a report on Monday.Ozempic took the weight loss sector by storm in 2023, ...

04 Oct, 2023 Insomnia treatment market faces need for innovation as Z-drugs show limitations, says GlobalData Share Print...

28 Sep, 2023 Intercept acquisition by Alfasigma reflects NASH failure, says GlobalData Share Print page ...

The psychedelic drug market is on the brink of extraordinary growth, projected to soar to $7.2 billion by 2029, reflecting a robust 55 per cent compound annual growth rate (CAGR), according to a report on Monday.This ascent is propelled by ...